<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="2120">
  <stage>Registered</stage>
  <submitdate>26/09/2008</submitdate>
  <approvaldate>26/09/2008</approvaldate>
  <nctid>NCT00762502</nctid>
  <trial_identification>
    <studytitle>Comparison of Senofilcon A Toric Lenses to Balafilcon A Toric Lenses Over Extended Wear Period</studytitle>
    <scientifictitle>Comparison of Senofilcon A Toric Lenses to Balafilcon A Toric Lenses Over Extended Wear Period</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>CR-4498</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Astigmatism</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - senofilcon A toric contact lens
Treatment: devices - balafilcon A toric contact lens

Active Comparator: senofilcon A toric bilaterally - senofilcon A lenses worn daily bilaterally (in both eyes) for 3 months, replaced weekly.

Active Comparator: balafilcon A toric bilaterally - balafilcon A lenses worn daily bilaterally (in both eyes) for 3 months, replaced weekly.

Active Comparator: senofilcon A/balafilcon A contralaterally - senofilcon A lens worn in one eye and balafilcon A lens worn in the other eye (contralaterally), daily for 3 months, replaced weekly.


Treatment: devices: senofilcon A toric contact lens
soft contact lens

Treatment: devices: balafilcon A toric contact lens
soft contact lens

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Corneal Staining - Scale of 0 to 4; 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe. The subjects were assigned to senofilcon A toric/balafilcon A toric contralaterally or senofilcon A or balafilcon A lenses bilaterally.</outcome>
      <timepoint>at 3 months of lens wear (period 1)</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Limbal Redness - Scale of 0 to 4; 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe. The subjects were assigned to senofilcon A toric/balafilcon A toric contralaterally or senofilcon A or balafilcon A lenses bilaterally.</outcome>
      <timepoint>at 3 months of lens wear (period 1)</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Bulbar Redness - Scale of 0 to 4; 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe. The subjects were assigned to senofilcon A toric/balafilcon A toric contralaterally or senofilcon A or balafilcon A lenses bilaterally.</outcome>
      <timepoint>at 3 months of lens wear (period 1)</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Tarsal Roughness - Scale of 0 to 4; 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe. The subjects were assigned to senofilcon A toric/balafilcon A toric contralaterally or senofilcon A or balafilcon A lenses bilaterally.</outcome>
      <timepoint>at 3 months of lens wear (period 1)</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Able to wear study lenses in parameters available

          -  Non-presbyopes between the ages of 18-45

          -  Understand and sign informed consent

          -  Willing to follow the protocol

          -  Achieve at least 20/30 (6/9) visual acuity (VA) in right eye (OD) and left eye (OS)
             with study lenses

          -  Myopia -0.75 to -6.25, cylinder -0.75 to -1.50 diopters (D) (axis 90 +/- 15, 180 +/-
             15) or -1.75 D (axis 90 +/- 10, 180 +/- 10)

          -  Adapted soft contact lens wearer

          -  Swims no more than once a week

          -  Has a wearable pair of spectacles.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Any ocular or systemic disorder which may contraindicate contact lens wear

          -  Any topical ocular medication

          -  Aphakic

          -  Corneal refractive surgery

          -  Corneal distortion from hard CL wear or keratoconus

          -  Pregnant or lactating

          -  Grade 2 or worse slit lamp signs

          -  Infectious disease

          -  Previous clinical study within 2 weeks

          -  Don't agree to participate

          -  Polymethyl methacrylate (PMMA) or rigid gas-permeable (RGP) lens wear in last 8 weeks

          -  Previous adverse effects that contraindicate extended lens wear.

          -  Self-reported symptoms of itchiness or scratchiness with habitual lenses.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose />
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/06/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>112</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/01/2008</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,VIC</recruitmentstate>
    <hospital> - Newtown</hospital>
    <hospital> - Camberwell</hospital>
    <hospital> - Hawthorn</hospital>
    <hospital> - Keilor</hospital>
    <hospital> - Melbourne</hospital>
    <hospital> - Mitcham</hospital>
    <hospital> - Moe</hospital>
    <postcode>2042 - Newtown</postcode>
    <postcode>3124 - Camberwell</postcode>
    <postcode>3122 - Hawthorn</postcode>
    <postcode>3036 - Keilor</postcode>
    <postcode>3000 - Melbourne</postcode>
    <postcode>3132 - Mitcham</postcode>
    <postcode>3825 - Moe</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Massachusetts</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Johnson &amp; Johnson Vision Care, Inc.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>To evaluate two toric contact lenses on the ocular physiology of existing contact lens
      wearers when used in an extended wear modality of days/six nights.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00762502</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>